Oppenheimer reissued their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Oppenheimer currently has a $18.00 price objective on the stock. Several other analysts also recently commented on the stock. StockNews.com downgraded shares of Voyager Therapeutics from a buy rating to […]
Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Monday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.
ZIVO Bioscience (NASDAQ:ZIVO) and Neurocrine Biosciences (NASDAQ:NBIX) Head to Head Comparison themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.